K562 cell sensitization to 5-fluorouracil- or interferon-alpha-induced apoptosis via cordycepin (3′-deoxyadenosine):: Fine control of cell apoptosis via poly(A) polymerase upregulation

被引:13
作者
Lallas, GC
Courtis, N [1 ]
Havredaki, M
机构
[1] St Savvas Hosp, Papanikolaou Res Ctr, Dept Biochem & Mol Biol, Athens, Greece
[2] NCSR Demokritos, Inst Biol, GR-15310 Athens, Greece
关键词
polyadenylation; drug resistance; apoptosis; cordlycepin; 5-fluorouracil; interferon-alpha; poly(A) polymerase;
D O I
10.1177/172460080401900108
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
K562 cells represent a classical model for the study of drug resistance. Induction of apoptosis is accompanied by concomitant distinct modulations of poly(A) polymerase (PAP) and other proteins involved in mRNA maturation. Recent data suggest the involvement of mRNA stability in the induction of specific apoptosis pathways. In this study we used a specific polyadenylation inhibitor, cordycepin (3-deoxyadenosine), to investigate the involvement of polyadenylation in K562 cell apoptosis and drug resistance. The combination of cordycepin with either 5-fluorouracil or interferon-alpha sensitized chemoresistant K562 cells to apoptosis. This sensitization was followed by distinct PAP modulations before and after the appearance of characteristic apoptosis pointers (DNA laddering, DAPI staining, mitochondrial transmembrane potential). PAP modulations appeared essential for K562 sensitization. mRNA polyadenylation therefore seemed to be involved not only in apoptosis but also in drug resistance. Polyadenylation inhibition by cordycepin under certain conditions sensitized chemoresistant K562 cells to apoptosis and thus polyadenylation could prove to be a fine target for overcoming drug resistance.
引用
收藏
页码:58 / 66
页数:9
相关论文
共 72 条
  • [1] Dephosphorylation, proteolysis, and reduced activity of Poly(A) polymerase associated with U937 cell apoptosis
    Atabasides, H
    Tsiapalis, CM
    Havredaki, M
    [J]. EXPERIMENTAL CELL RESEARCH, 1998, 244 (02) : 433 - 440
  • [2] Poly(A) polymerase specifically implicated in the mechanism of chemotherapeutic drug action during cell apoptosis
    Atabasides, H
    Tsiapalis, CM
    Havredaki, M
    [J]. INTERNATIONAL JOURNAL OF BIOLOGICAL MARKERS, 2000, 15 (01) : 10 - 14
  • [3] Anticancer drug action on poly(A) polymerase activity and isoforms during HeLa and WISH cell apoptosis
    Balatsos, NAA
    Havredaki, M
    Tsiapalis, CM
    [J]. INTERNATIONAL JOURNAL OF BIOLOGICAL MARKERS, 2000, 15 (02) : 171 - 178
  • [4] Early 5-fluorouracil-induced changes of poly(A) polymerase in HeLa and WISH cells
    Balatsos, NAA
    Havredaki, M
    Tsiapalis, CM
    [J]. INTERNATIONAL JOURNAL OF BIOLOGICAL MARKERS, 2000, 15 (04) : 294 - 299
  • [5] Balatsos NAA, 2001, J EXP CLIN CANC RES, V20, P63
  • [6] BALLANTYNE S, 1995, RNA, V1, P64
  • [7] Last but not least: Regulated poly(A) tail formation
    Barabino, SML
    Keller, W
    [J]. CELL, 1999, 99 (01) : 9 - 11
  • [8] ACTIVATION OF PROGRAMMED CELL-DEATH (APOPTOSIS) BY CISPLATIN, OTHER ANTICANCER DRUGS, TOXINS AND HYPERTHERMIA
    BARRY, MA
    BEHNKE, CA
    EASTMAN, A
    [J]. BIOCHEMICAL PHARMACOLOGY, 1990, 40 (10) : 2353 - 2362
  • [9] BCR-ABL-MEDIATED INHIBITION OF APOPTOSIS WITH DELAY OF G2/M TRANSITION AFTER DNA-DAMAGE - A MECHANISM OF RESISTANCE TO MULTIPLE ANTICANCER AGENTS
    BEDI, A
    BARBER, JP
    BEDI, GC
    ELDEIRY, WS
    SIDRANSKY, D
    VALA, MS
    AKHTAR, AJ
    HILTON, J
    JONES, RJ
    [J]. BLOOD, 1995, 86 (03) : 1148 - 1158
  • [10] Bollum F J, 1974, Methods Enzymol, V29, P70